After the transplantation of UC‐MSCs, the lymphocyte count, including CD4+ T‐cell subsets, CD8+ T‐cell subsets and NK cells, were increased, which suggested the immunomodulation effect of UC‐MSCs may play an important role in the COVID‐19 treatment. Here, CD8A is linked to COVID-19.